In normotensive adults with diabetes, does adding an ARB or ACE-inhibitor reduce cardiovascular events?

Madeleine Davies; Tera Meerkins; Dana Brandenburg; Carrie Link

doi:10.1097/ebp.0000000000001678

In normotensive adults with diabetes, does adding an ARB or ACE-inhibitor reduce cardiovascular events?

Madeleine Davies
, Tera Meerkins
, Dana Brandenburg
, Carrie Link

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	17-18
Number of pages	2
Journal	Evidence-Based Practice
Volume	26
Issue number	1
DOIs	https://doi.org/10.1097/ebp.0000000000001678
State	Published - Jan 31 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1097/ebp.0000000000001678

Find It

Find It at U of M Libraries

Cite this

@article{e4030c875e9f46af8ea7a465e24bf1d0,

title = "In normotensive adults with diabetes, does adding an ARB or ACE-inhibitor reduce cardiovascular events?",

author = "Madeleine Davies and Tera Meerkins and Dana Brandenburg and Carrie Link",

year = "2023",

month = jan,

day = "31",

doi = "10.1097/ebp.0000000000001678",

language = "English (US)",

volume = "26",

pages = "17--18",

journal = "Evidence-Based Practice",

issn = "1095-4120",